CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $11,000 | -47.6% | 4,919 | -63.8% | 0.00% | – |
| Q4 2017 | $21,000 | +320.0% | 13,590 | +547.1% | 0.00% | – |
| Q3 2017 | $5,000 | -90.7% | 2,100 | -82.7% | 0.00% | – |
| Q2 2017 | $54,000 | -54.2% | 12,140 | -68.9% | 0.00% | – |
| Q1 2017 | $118,000 | -35.2% | 39,000 | -40.4% | 0.00% | – |
| Q4 2016 | $182,000 | +83.8% | 65,406 | +106.4% | 0.00% | – |
| Q3 2016 | $99,000 | -23.3% | 31,696 | +25.5% | 0.00% | – |
| Q2 2016 | $129,000 | +514.3% | 25,255 | +399.9% | 0.00% | – |
| Q1 2016 | $21,000 | -85.4% | 5,052 | -71.7% | 0.00% | – |
| Q4 2015 | $144,000 | -49.8% | 17,825 | -47.7% | 0.00% | – |
| Q3 2015 | $287,000 | +19.6% | 34,057 | +33.8% | 0.00% | – |
| Q2 2015 | $240,000 | +15.4% | 25,461 | +13.3% | 0.00% | – |
| Q1 2015 | $208,000 | +56.4% | 22,465 | +56.1% | 0.00% | – |
| Q4 2014 | $133,000 | -8.3% | 14,388 | -11.1% | 0.00% | – |
| Q3 2014 | $145,000 | -57.0% | 16,188 | -62.2% | 0.00% | – |
| Q2 2014 | $337,000 | +137.3% | 42,833 | +139.1% | 0.00% | – |
| Q1 2014 | $142,000 | +19.3% | 17,916 | -6.5% | 0.00% | – |
| Q4 2013 | $119,000 | – | 19,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |